KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) Invested Capital (2016 - 2025)

Historic Invested Capital for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $53.3 billion.

  • Merck's Invested Capital rose 1174.41% to $53.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $53.3 billion, marking a year-over-year increase of 1174.41%. This contributed to the annual value of $49.0 billion for FY2024, which is 2567.23% up from last year.
  • Per Merck's latest filing, its Invested Capital stood at $53.3 billion for Q3 2025, which was up 1174.41% from $50.5 billion recorded in Q2 2025.
  • Merck's 5-year Invested Capital high stood at $53.3 billion for Q3 2025, and its period low was $34.3 billion during Q1 2021.
  • Over the past 5 years, Merck's median Invested Capital value was $46.3 billion (recorded in 2022), while the average stood at $44.5 billion.
  • Per our database at Business Quant, Merck's Invested Capital soared by 2904.73% in 2022 and then plummeted by 1874.22% in 2023.
  • Merck's Invested Capital (Quarter) stood at $40.7 billion in 2021, then increased by 18.04% to $48.0 billion in 2022, then decreased by 18.74% to $39.0 billion in 2023, then increased by 25.67% to $49.0 billion in 2024, then increased by 8.75% to $53.3 billion in 2025.
  • Its Invested Capital was $53.3 billion in Q3 2025, compared to $50.5 billion in Q2 2025 and $49.8 billion in Q1 2025.